Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Beiersdorf Wants Nivea ‘Unapproved Drug’ Suit Off Its Back Once And For All; L’Oreal Likely Watching

Apr 04 2019

• By Ryan Nelson

Monkey On Back

Related Content

FDA Serves Up More Warnings: Avon Cited For Touting Druglike Benefits

Oct 22 2012

L’Oreal’s Anti-Wrinkle RevitaLift Products Are Unlawfully Marketed Drugs – Class Action Complaint

Apr 04 2019

Appeals Court To Hear Suit Alleging <em>Nivea</em> Lotion Is Unlawfully Marketed Drug

May 16 2017

FDA Warns Another 'Stem Cell' Skin Care Marketer On Drug Claims

Jun 14 2016

Related Companies

Beiersdorf AG

Additional Topics

Legal Issues Cosmetics Business Strategies Consumer

More from Strategy

More from Business

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.